After hours of planning and anticipation, we were thrilled to see all of the hard work of the diabetes community culminate in the unprecedented patient discussion with the FDA on Nov. 3. It would not have been possible without the enormous help of the FDA staff who so generously agreed to partner with us, and the thousands of patients who have made their voices heard by taking the survey, spreading the word, and tuning in for the event.

Read more